SCHEMBL4397722

SCHEMBL4397722

CCOC(=O)COc1cc(OC)c2c(=O)cc(-c3ccc(OC)c(OC)c3)oc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.70
ALDH1A1 P00352 3/20 0.70
CYP1A2 P05177 2/20 0.70
POLB P06746 2/20 0.70
CYP2C9 P11712 2/20 0.70
HPGD P15428 2/20 0.70
CYP2C19 P33261 2/20 0.70
CYP3A4 P08684 2/20 0.70
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
ABCB1 P08183 3/20 0.55
ABCG2 Q9UNQ0 2/20 0.55
TP53 P04637 1/20 0.55
MDM2 Q00987 1/20 0.55
CYP1B1 Q16678 2/20 0.54
CYP1A1 P04798 1/20 0.53
OPRD1 P41143 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
MAPT P10636 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8427187 0.95 KDM4E (0.74) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL4393314 0.92 CYP1B1 (0.67) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL14178905 0.91 ABCB1 (0.58) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL10472448 0.89 CYP1A2 (0.63) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL8429151 0.88 KDM4E (0.65) KDM4EALDH1A1CYP1A2POLBCYP2C9
Recoflavone SCHEMBL2483541 0.87 ABCB1 (0.59) KDM4EALDH1A1CYP1A2POLBCYP2C9
Recoflavone SCHEMBL29406117 0.87 ABCB1 (0.59) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL2481857 0.87 MEN1 (0.59) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL8427271 0.87 KDM4E (0.64) KDM4EALDH1A1CYP1A2POLBCYP2C9
SCHEMBL4397861 0.87 MAPT (0.70) KDM4EALDH1A1CYP1A2POLBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660074-B1 7-CARBOXYMETHYLOXY-3 , 4 , 5-TRIMETHOXY FLAVONE MONOHYD RATE, THE PREPARATION METHOD AND USES THEREOF DONG A PHARM CO LTD (KR) 2009-12-16 EP disclosed
EP-2065375-A1 A process for the preparation of 7-carboxymethyloxy-3',4', 5-trimethoxy flavone Dong-A Pharmaceutical Co., Ltd. (KR) 2009-06-03 EP disclosed
US-7371775-B2 7-carboxymethyloxy-3′,4′,5-trimethoxy flavone monohydrate, the preparation method and uses thereof DONG-A PHARMACEUTICALS CO., LTD (KR) 2008-05-13 US disclosed
US-20060178428-A1 7-Carboxymethyloxy-3',4',5-trimethoxy flavone monohydrate, the preparation method and uses thereof DONG-A PHARMACEUTICAL CO., LTD (KR) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178428-A1 7-Carboxymethyloxy-3',4',5-trimethoxy flavone monohydrate, the preparation method and uses thereof SI, MLN, TET2 KDM4E 86/4885ALDH1A1 1642/4885CYP1A2 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.